Discover capabilities
Explore assets and services for research, technical evaluation, inference and traceability.
Explore the initial Data Products in the EDGE/DM pilot data space: datasets, inference services, benchmarks and traceability capabilities for MedTech use cases.
All entries are published as governed candidates validated in the sandbox. Operational access remains subject to connector/runtime availability, eligibility review, DUA/DUP and a traceable decision.
Each entry describes its purpose, intended uses, restrictions, available evidence and access model to support controlled and transparent MedTech collaboration.
Explore assets and services for research, technical evaluation, inference and traceability.
Each Data Product retains the usage conditions, restrictions and access decisions defined by its provider.
Requests, authorisations and executions can be documented through associated evidence and traces.
Controlled early-sepsis timeseries inference-only service for sandbox validation. It is not intended for clinical decision support or real diagnosis.
Controlled microscopy inference-only service for sandbox validation. It is not intended for real diagnosis or patient management.
Composite asset linking anonymised COVID-19 lateral-flow images with anonymised viral-load values. It is the governed reference base for the LFT reader benchmark.
Evaluate algorithms, applications and lateral-flow readers against anonymised images and associated viral-load values. Measure performance and robustness without exposing the reference set.
Compliance and traceability service for explanation generation, trace retrieval and audit review without declared access to primary medical data in v0.1.